pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
regdanvimab
regdanvimab [INN]
Coronavirus Disease 2019 (COVID-19)
Celltrion Inc
Marketed
regorafenib
Stivarga (regorafenib)
Recurrent Glioblastoma Multiforme (GBM)
Bayer AG
Marketed
relacorilant
Lifyorli (relacorilant)
Epithelial Ovarian Cancer
$CORT
CORCEPT THERAPEUTICS INC
Phase 2
← prev
page 212 of 231
next →
Pain
89
Neurology
1
relatlimab
relatlimab
Metastatic Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb Co
pre_registration
relutrigine
relutrigine [INN]
Epileptic Encephalopathy
$PRAX
Praxis Precision Medicines, Inc.
Phase 3
remestemcel-L
Prochymal (remestemcel-L)
Crohn's Disease (Regional Enteritis)
$MESO
MESOBLAST LTD
Phase 2
remetinostat
remetinostat
Cutaneous T-Cell Lymphoma
Biossil Inc
Marketed
remimazolam besylate
Byfavo (remimazolam besylate)
Sedation
Acacia Pharma Group Ltd
Phase 3
remlifanserin
remlifanserin
Alzheimer's Disease
$ACAD
ACADIA PHARMACEUTICALS INC
Phase 1
remzistotug
remzistotug
Breast Cancer
$GSK
GSK plc
Phase 2
rencofilstat
rencofilstat
Hepatocellular Carcinoma
$HEPA
Hepion Pharmaceuticals, Inc.
Phase 2
rentosertib acetate
rentosertib acetate
Idiopathic Pulmonary Fibrosis
InSilico Medicine
Marketed
repaglinide
Repaglinide
Type 2 Diabetes
Padagis LLC
Phase 3
repinatrabit
repinatrabit
Phenylketonuria (PKU)
Jnana Therapeutics Inc
Preclinical
repirinast
repirinast
Chronic Kidney Disease (Chronic Renal Failure)
$AGNPF
Algernon Health Inc.
Marketed
repotrectinib
Augtyro (repotrectinib)
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
Phase 3
resecabtagene autoleucel
resecabtagene autoleucel [INN]
Juvenile Dermatomyositis
$CABA
Cabaletta Bio, Inc.
Phase 3
resiniferatoxin
resiniferatoxin [INN]
Osteoarthritis Pain
Grunenthal GmbH
Phase 2
resiquimod
resiquimod
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
SURGE Therapeutics Inc
Phase 2
resiquimod sulfate
resiquimod sulfate
Squamous Non-Small Cell Lung Cancer
$EIKN
Eikon Therapeutics, Inc.
Marketed
reslizumab
Cinqair (reslizumab)
Eosinophilic Asthma
Teva Pharmaceuticals USA Inc
Phase 2
resomelagon acetate
resomelagon acetate
Rheumatoid Arthritis
SynAct Pharma AB
Phase 2
respiratory syncytial virus vaccine
mRESVIA
Respiratory Syncytial Virus (RSV) Infections
$MRNA
Moderna, Inc.
Marketed
reteplase
Retavase (reteplase)
Congestive Heart Failure (Heart Failure)
Chiesi USA Inc
Phase 3
retogatein
Diamyd (retogatein)
Type 1 Diabetes (Juvenile Diabetes)
Diamyd Medical AB
Marketed
revakinagene taroretcel
Encelto (revakinagene taroretcel-iwey)
Idiopathic Juxtafoveolar Retinal Telangiectasis (IJRT)
Neurotech Pharmaceuticals Inc
Marketed
revefenacin
Yupelri (revefenacin)
Chronic Obstructive Pulmonary Disease (COPD)
Theravance Biopharma US Inc
Phase 3
rexlemestrocel-L
Revascor (rexlemestrocel-L)
Hypoplastic Left Heart Syndrome
$MESO
MESOBLAST LTD
Phase 2
rezatapopt
rezatapopt
Bile Duct Cancer (Cholangiocarcinoma)
$PMVP
PMV Pharmaceuticals, Inc.
Phase 2
rezpegaldesleukin
rezpegaldesleukin
Alopecia Areata
$NKTR
NEKTAR THERAPEUTICS
